Z. Surmeli Et Al. , "Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway," Tumor Biology , vol.37, no.3, pp.3665-3673, 2016
Surmeli, Z. Et Al. 2016. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway. Tumor Biology , vol.37, no.3 , 3665-3673.
Surmeli, Z., Gursoy, P., Erdogan, A. P., Bozkurt, E., ATMACA İLHAN, H., Uzunoglu, S., ... Sezgin, C.(2016). Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway. Tumor Biology , vol.37, no.3, 3665-3673.
Surmeli, Zeki Et Al. "Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway," Tumor Biology , vol.37, no.3, 3665-3673, 2016
Surmeli, Zeki Et Al. "Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway." Tumor Biology , vol.37, no.3, pp.3665-3673, 2016
Surmeli, Z. Et Al. (2016) . "Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway." Tumor Biology , vol.37, no.3, pp.3665-3673.
@article{article, author={Zeki Surmeli Et Al. }, title={Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway}, journal={Tumor Biology}, year=2016, pages={3665-3673} }